Drug intelligence / Profile preview

REPHADERM

Development stage: Unknown
Lead developer: Repha
Modality: Small Molecules
Administration: Topical

Overview

REPHADERM is a topical intensive balm developed by Repha GmbH Biologische Arzneimittel. It is a plant-based formulation containing extracts of Echinacea, sage (*Salvia officinalis*), rosemary (*Rosmarinus officinalis*), myrrh (*Commiphora myrrha*), and bitter wormwood (*Artemisia absinthium*) in an ointment base of olive oil, lanolin, petrolatum, and beeswax. Indicated for the protection and care of irritated and stressed skin, it helps soothe redness and itching while supporting skin regeneration through its cleansing and disinfecting properties. The formulation is based on a traditional recipe from the company's founder and is marketed as a cosmetic product in Germany.

Brand names: REPHADERMREPHADERM IntensivbalsamREPHADERM Balsam
Other names: REPHADERM-Repha

Beyond the preview

Go deeper on REPHADERM.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on REPHADERM.

Explore the full profile